Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

202221 citationsJournal Articlehybrid Open Access

Authors

Lung screening could be cost-effective in Australia, contingent on translating trial-like lung cancer mortality benefits to the clinic.

Good health and well-being

Published in: British Journal of Cancer

Volume 128, Issue 1, pp. 91-101

Field-Weighted Citation Impact: 2.89